封面
市場調查報告書
商品編碼
2039127

肉瘤切片檢查市場:按產品類型、最終用戶和地區分類

Sarcoma Biopsy Market, By Product Type (Reusable Device and Disposable Devices), By End User (Hospitals, Ambulatory Surgical Centers, and Diagnostic Centers), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

出版日期: | 出版商: Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2026年肉瘤切片檢查市場規模估計為138億美元,預計2033年將達到193億美元。預計2026年至2033年,該市場將以7.2%的複合年成長率成長。

分析範圍 分析詳情
基準年 2025 市場規模(2026 年) 138億美元
效能數據 2020-2024 預測期 2026-2033
預測期(2026-2033 年)複合年成長率 7.20% 預計金額(2033 年) 193億美元

肉瘤是一種發生於結締組織的癌症。肉瘤大致可分為兩類:軟組織肉瘤和骨癌。軟組織肉瘤發生於血管、神經、肌腱、肌肉、脂肪和關節膜等組織。軟組織肉瘤主要發生於腿部、手臂、腹部和胸部。目前已知的軟組織肉瘤超過50種。軟組織肉瘤的症狀包括出現腫塊、腹痛、血便和嘔吐。

市場動態

受骨癌發生率不斷上升的推動,全球肉瘤切片檢查市場預計在預測期內將顯著成長。例如,根據美國臨床腫瘤學會(ASCO)的數據,2018年美國約有3,450例新增骨癌病例,骨癌死亡病例總數為1,590例。

骨癌可以透​​過電腦斷層掃描(CT)、骨骼掃描、磁振造影(MRI)、正子斷層掃描(PET)和切片檢查等影像技術進行診斷。

本報告的主要特點

  • 本報告揭示了各個細分市場的潛在商機,並描述了該市場中一系列有吸引力的投資提案。
  • 此外,它還提供了有關市場促進因素和限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
  • 本節根據公司概況、產品系列、主要亮點、財務表現和策略等各種參數,對全球肉瘤切片檢查市場的主要公司進行介紹。
  • 本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、產品線更新、市場擴張和行銷策略做出明智的決策。
  • 《全球肉瘤切片檢查市場》報告面向業內廣泛的相關人員,包括投資者、產品製造商、經銷商、供應商、研究和諮詢公司、新進業者和金融分析師。

目錄

第1章:分析目標與假設

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機遇
  • 市場機遇
  • 影響分析
  • 市場趨勢
  • 主要活動
  • PEST分析
  • 波特五力模型

第4章:全球肉瘤切片檢查市場:依產品類型分類(2021-2033 年)

  • 可重複使用設備
  • 免洗設備

第5章 全球肉瘤切片檢查市場:依最終使用者分類(2021-2033 年)

  • 醫院
  • 門診手術中心
  • 診斷中心

第6章 全球肉瘤切片檢查市場:按地區分類(2021-2033 年)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • ASEAN
    • 澳洲
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 非洲
    • 北非
    • 中非
    • 南部非洲
  • 中東
    • 波灣合作理事會(GCC)國家
    • 以色列
    • 其他中東國家

第7章 競爭情勢

  • 公司簡介
    • CR Bard, Inc
    • Becton, Dickinson and Company
    • Argon Medical Devices
    • InVivo Therapeutics Corporation
    • Cook Medical Incorporated
    • UROMED
    • Sterylab

第8章

  • 參考
  • 分析方法
簡介目錄
Product Code: CMI3819

Sarcoma Biopsy Market is estimated to be valued at USD 13.8 Bn in 2026 and is expected to reach USD 19.3 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.2% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 13.8 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 7.20% 2033 Value Projection: USD 19.3 Bn

Sarcoma is a type of cancer, which occurs in connective tissues. Moreover, sarcoma is broadly classified into two types such as soft tissue sarcoma and bone sarcoma. Soft tissue sarcomas occur in tissues of blood vessels, nerves, tendons, muscles, fat, and lining of the joints. Soft tissue sarcomas are mostly found in legs, arms, abdomen, and chest. There are over 50 types of soft tissue sarcoma. Soft tissue sarcoma symptoms include lump growth, abdominal pain, blood in stools, and vomiting

Market Dynamics

The global sarcoma biopsy market is expected to witness significant growth during the forecast period, owing to increasing prevalence of bone cancer. For instance, according to the American Society of Clinical Oncology, in 2018, around 3,450 new cases of bone cancer were registered and total 1,590 deaths occurred due to bone cancer in the U.S.

Bone cancer can be diagnosed using imaging techniques such as computerized tomography (CT), bone scan, magnetic resonance imaging (MRI), positron emission tomography (PET) scanning, and biopsy tests.

Key features of the study

  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global sarcoma biopsy market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include R. Bard, Inc., Becton, Dickinson and Company, Argon Medical Devices, InVivo Therapeutics Corporation, Cook Medical Incorporated, UROMED, and Sterylab
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, government initiatives, technological upgradation, market expansion, and marketing tactics
  • The global sarcoma biopsy market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for Surgical Cushions Market, research and consulting firms, new entrants, and financial analysts

Market Segmentation

  • By Product Type
    • Reusable Device
    • Disposable Devices
  • By End User
    • Hospitals
    • Ambulatory Surgical Centers
    • Diagnostic Centers
  • By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Key Players
    • C.R. Bard Inc
    • Becton, Dickinson and Company
    • Argon Medical Devices
    • InVivo Therapeutics Corporation
    • Cook Medical Incorporated
    • UROMED
    • Sterylab

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • PEST Analysis
  • Porter's Five Forces model

4. Global Sarcoma Biopsy Market, By Product Type, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021-2033
    • Segment Trends
  • Reusable Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Disposable Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Sarcoma Biopsy Market, By End User, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021-2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Diagnostic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Sarcoma Biopsy Market, By Region, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2026, and 2033 (%)
    • Y-o-Y Growth Analysis, By Region, 2021-2033
    • Regional Trends
  • North America
    • Market Size and Forecast, By Product Type, 2021-2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021-2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
      • U.S.
      • Canada
  • Europe
    • Market Size and Forecast, By Product Type, 2021-2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021-2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2021-2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021-2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
      • China
      • Japan
      • India
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Product Type, 2021-2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021-2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Product Type, 2021-2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021-2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa
  • Middle East
    • Market Size and Forecast, By Product Type, 2021-2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021-2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East

7. Competitive Landscape

  • Company Profiles
    • C. R. Bard, Inc
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Becton, Dickinson and Company
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Argon Medical Devices
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • InVivo Therapeutics Corporation
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Cook Medical Incorporated
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • UROMED
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Sterylab
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies

8. Section

  • References
  • Research Methodology
  • About Us and Sales Contact